Shiran Huang Selected Research

Acetyl Coenzyme A (Acetyl-CoA)

5/2023

A new strategy to alleviate the obesity induced by endocrine disruptors-A unique lysine metabolic pathway of nanoselenium Siraitia grosvenorii to repair gut microbiota and resist obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiran Huang Research Topics

Disease

2	Obesity 05/2023 - 01/2021
2	Inflammation (Inflammations) 12/2022 - 11/2021
2	Neoplasms (Cancer) 12/2020 - 01/2020
1	Dysbiosis 12/2023
1	Infections 10/2018

Drug/Important Bio-Agent (IBA)

2	Endocrine DisruptorsIBA 05/2023 - 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2023
1	Lysine (L-Lysine)FDA Link 05/2023
1	16S Ribosomal RNAIBA 05/2023
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2022
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 12/2022
1	(2,9- dimethyl- 1,10- phenanthroline)(thiophenolato)copper(I)IBA 12/2022
1	LipidsIBA 11/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021
1	CarcinogensIBA 12/2020
1	dorsomorphinIBA 12/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2020
1	DNA VaccinesIBA 10/2018

Therapy/Procedure

1	Injections 12/2022